🇺🇸 Erythopoietin stimulating agent in United States

Erythopoietin stimulating agent (Erythopoietin stimulating agent) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Erythopoietin stimulating agent in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Erythopoietin stimulating agent approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Erythopoietin stimulating agent in United States?

Imperial College Healthcare NHS Trust is the originator. The local marketing authorisation holder may differ — check the official source linked above.